Article
CAR T cells and T cells phenotype and function are impacted by glucocorticoid exposure with different amplitude.
2023-10-10
Abstract excerpt
<title>Abstract</title> <p><bold>Background. </bold> Chimeric antigen receptor (CAR) T cell therapy is associated with high risk of adverse events. Glucocorticoids (GCs) are cornerstone in the management of high-grade cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS). Given the potentially deleterious effects of GCs on CAR T cells anti-tumor activity, increasing ou...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a7f6f051-277e-59f5-8c22-0e7ca32ad65a
- DOI
- 10.21203/rs.3.rs-3366592/v1
